These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2407166)

  • 61. Meshed capillary vessels found on narrow-band imaging without optical magnification effectively identifies colorectal neoplasia: a North American validation of the Japanese experience.
    Henry ZH; Yeaton P; Shami VM; Kahaleh M; Patrie JT; Cox DG; Peura DA; Emura F; Wang AY
    Gastrointest Endosc; 2010 Jul; 72(1):118-26. PubMed ID: 20381799
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma.
    Tibble J; Sigthorsson G; Foster R; Sherwood R; Fagerhol M; Bjarnason I
    Gut; 2001 Sep; 49(3):402-8. PubMed ID: 11511563
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Sensitivity of immunochemical occult blood testing in detecting early colorectal cancer].
    Saito H
    Nihon Rinsho; 1996 May; 54(5):1421-4. PubMed ID: 8965378
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Screening for colorectal tumors using fecal occult blood studies].
    Restellini A; Margalith D; Bauerfeind P; Guyot J; Ollyo JB; Gonvers JJ; Blum AL
    Ther Umsch; 1989 Jun; 46(6):389-97. PubMed ID: 2667190
    [TBL] [Abstract][Full Text] [Related]  

  • 65. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.
    Lieberman DA; Weiss DG;
    N Engl J Med; 2001 Aug; 345(8):555-60. PubMed ID: 11529208
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Sensitivity of hemoccult testing in patients with colorectal carcinoma.
    Wexner SD; Brabbee GW; Wichern WA
    Dis Colon Rectum; 1984 Dec; 27(12):775-6. PubMed ID: 6499615
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Hemoccult should no longer be used for the screening of colorectal cancer.
    Bleiberg H
    Ann Oncol; 2002 Jan; 13(1):44-6. PubMed ID: 11863109
    [No Abstract]   [Full Text] [Related]  

  • 68. Fecal occult blood testing for colorectal cancer screening: use the finger.
    Burke CA; Tadikonda L; Machicao V
    Am J Gastroenterol; 2001 Nov; 96(11):3175-7. PubMed ID: 11721767
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [The role of and suitability of the occult fecal blood test in a preventive program for colorectal carcinoma].
    Ebling Z; Hadzić N
    Lijec Vjesn; 1989 Dec; 111(12):432-6. PubMed ID: 2636303
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Sensitivity of the Hemoccult II slide test in detecting colonic neoplasms.
    Poleski MH; Gordon PH
    Can J Surg; 1986 Mar; 29(2):99-101. PubMed ID: 3955472
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Occult blood testing in asymptomatic patients previously resected for colorectal cancer.
    Aste H; Giacchero A; Pugliese V; Santi L
    Cancer Detect Prev; 1984; 7(4):237-40. PubMed ID: 6488214
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cost benefits of hemoccult screening for colorectal carcinoma.
    Allison JE; Feldman R
    Dig Dis Sci; 1985 Sep; 30(9):860-5. PubMed ID: 3928287
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cost-effectiveness of colonoscopy in screening for colorectal cancer.
    Sonnenberg A; Delcò F; Inadomi JM
    Ann Intern Med; 2000 Oct; 133(8):573-84. PubMed ID: 11033584
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Population screening for colorectal carcinoma by examining feces for occult hemorrhage].
    Musil D
    Vnitr Lek; 1999 Aug; 45(8):496-9. PubMed ID: 11045153
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Hemoccult screening for colorectal cancer.
    Chang FC; Jackson TM; Jackson CR
    Am J Surg; 1988 Dec; 156(6):457-9. PubMed ID: 3202256
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Screening for colon cancer: A test for occult blood.
    Khakimov N; Khasanova G; Ershova K; Gibadullina L; Vetkina T; Lobisheva G; Chumakova A
    Int J Risk Saf Med; 2015; 27 Suppl 1():S110-1. PubMed ID: 26639687
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [[Evaluation of various methods of studying fecal occult blood].
    Vandenbroucke A; Bourdon C; Ilunga J
    Acta Gastroenterol Belg; 1988; 51(4-5):383-90. PubMed ID: 2979053
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Mass screening for colorectal cancer.
    Khubchandani IT; Karamchandani MC; Kleckner FS; Sheets JA; Stasik JJ; Rosen L; Riether RD
    Dis Colon Rectum; 1989 Sep; 32(9):754-8. PubMed ID: 2503341
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Community screening for colorectal cancer in north-eastern New South Wales, 1987-1996.
    Rae LC
    Med J Aust; 1998 Apr; 168(8):382-5. PubMed ID: 9594947
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Fecal occult blood test--the importance of proper evaluation.
    Niv Y
    J Clin Gastroenterol; 1990 Aug; 12(4):393-5. PubMed ID: 2398247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.